Evaluation of the impact of Roclaglamide on MDA-MB-231 human breast adenocarcinoma cells by cell culture and molecular approaches

Ruaa Sandakli; Ismail Saadoun; Ban Al-Joubori; Muhammad Nasir Khan Khattak

doi:10.1007/s44446-025-00023-5

Citations

387

Views

Abstract not available for this publication.

Cite this Article (APA)

Ruaa, S., Ismail, S., Ban, A., Muhammad, N. K. K. (2025). Evaluation of the impact of Roclaglamide on MDA-MB-231 human breast adenocarcinoma cells by cell culture and molecular approaches. Saudi Pharmaceutical Journal. https://doi.org/10.1007/s44446-025-00023-5

Rabia Gul; Hamid Bashir; Muhammad Sarfraz; Ahson Jabbar Shaikh; Yousef A. Bin Ja · 2024

cites

395

Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems

Kampanart Huanbutta; Vivek Puri; Ameya Sharma; Inderbir Singh; Pornsak Sriamorns · 2024

cites

391

A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities

Hussain A. Al-Omar; Ali Alshehri; Saleh A. Alqahtani; Hana Alabdulkarim; Ali Alr · 2024

cites

394

Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management …